Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
See top OEM and Custom options in the marketContact us for more details
doi:10.1093/advances/nmac094 100
The patents held by the manufacturers, Novo Nordisk (for Ozempic and Wegovy) and Eli Lilly (for Mounjaro and Zepbound), prevent other companies from producing generic equivalents for several more years
Tirzepatide is a dual-action medication, targeting two different pathways GLP-1 and GIP
Retatrutide achieved up to 24.2% body weight reduction in 48 weeks in Phase 2, and the recently completed Phase 3 TRIUMPH-4 trial pushed that number to an unprecedented 28.7% at 68 weeks
Administered subcutaneously, PT-141 supports hypothalamic activation and neurotransmitter modulation in controlled research settings
US$ 29.86
US$ 21.30
US$ 22.10
US$ 22.43
US$ 23.70
US$ 22.27
